scispace - formally typeset
Journal ArticleDOI

Ghrelin and autophagy.

Reads0
Chats0
TLDR
Ghrelin represents an attractive target for development of therapeutics for prevention or treatment of metabolic, cardiac or neuronal disorders, in which autophagy is impaired.
Abstract
Purpose of reviewA compromised autophagy is associated with the onset of obesity, type 2 diabetes, nonalcoholic fatty liver disease, cardiovascular and neurodegenerative diseases Our aim is to review the potential role of ghrelin, a gut hormone involved in energy homeostasis, in the regulation of a

read more

Citations
More filters
Journal ArticleDOI

Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk.

TL;DR: This review describes the relevance of specific adipokines in the obesity-associated cardiovascular disease and the mechanisms underlying adipose tissue dysfunction including adipocyte hypertrophy and hyperplasia, increased inflammation, impaired extracellular matrix remodeling, and fibrosis.
Journal ArticleDOI

Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management

TL;DR: Accumulating evidence has recently suggested a pivotal role for proteotoxicity, the unfavorable effects of poor protein quality control, in the pathophysiology of metabolic dysregulation and related cardiovascular complications, and autophagy offers promising targets for novel strategies to prevent and treat cardiorenal metabolic diseases.
Journal ArticleDOI

SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes

TL;DR: Assessment of the effect of the SGLT2 inhibitor empagliflozin, the DPP4 inhibitor linagliptin, and their combination, on glomerular autophagy in a model of type 2 diabetes provides further explanation for the mechanism of the renoprotective effect of S GLT2 inhibitors and D PP4 inhibitors in diabetes.
Journal ArticleDOI

The Skeletal Muscle as an Active Player Against Cancer Cachexia.

TL;DR: Several observations suggest that the muscle reacts to the wasting drive imposed by cancer growth by activating different compensatory strategies that include anabolic capacity, the activation of autophagy and myogenesis.
References
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

mTOR: a pharmacologic target for autophagy regulation

TL;DR: An overview of the mTOR signaling pathway, the mechanisms of m TOR in autophagy regulation, and the clinical implications of mTOR inhibitors in disease treatment are provided.
Journal ArticleDOI

p62/SQSTM1 functions as a signaling hub and an autophagy adaptor.

TL;DR: The present review describes the current knowledge about p62 with regard to mammalian target of rapamycin complex 1 activation, the Keap1–Nrf2 pathway and selective autophagy.
Journal ArticleDOI

The cellular and molecular bases of leptin and ghrelin resistance in obesity.

TL;DR: The molecular mechanisms underpinning resistance to leptin and ghrelin are discussed and how they can be exploited as targets for pharmacological management of obesity are discussed.
Related Papers (5)